Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
4.5
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
2.4
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1 2.7
General Information
Revision date
2025-06-14
Product name
ESBRIET Tablets 801 mg
Product Synonyms
ESBRIET F.C. Tablets
1.2.1 Relevant identified uses
Formulated pharmaceutical active substance
supplier name
Genentech, Inc
Emergency telephone
001-(650) 225-1000, (800)-424-9300
Icons in SDS
Company Information
company name
Genentech, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H350
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H350 May cause cancer.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards
None known
2.1 Classification of the substance or mixture
1910.1200) Acute toxicity (Oral) : Category 4 Carcinogenicity
